Covered recipient · General Payments record
ERIN DODD MORELLA
Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine
General Payments · PY2018–2024
$3,196.82
- Reported across 193 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.66 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Collegium Pharmaceutical, Inc. | $55.18 | 3 |
| ABBVIE INC. | $51.79 | 2 |
| PFIZER INC. | $39.12 | 2 |
| Spinal Simplicity, LLC | $31.33 | 2 |
| SI-BONE, INC. | $22.23 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $20.20 | 1 |
| SCILEX PHARMACEUTICALS INC. | $19.91 | 1 |
| Medtronic, Inc. | $14.57 | 1 |
| Nevro Corp. | $14.53 | 1 |
| SPR Therapeutics, Inc | $3.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.10 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648306 | CMS |
| ABBVIE INC. | $23.69 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648308 | CMS |
| Boston Scientific Corporation | $20.20 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092452614 | CMS |
| Collegium Pharmaceutical, Inc. | $16.58 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135249019 | CMS |
| Collegium Pharmaceutical, Inc. | $19.75 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135346871 | CMS |
| Collegium Pharmaceutical, Inc. | $18.85 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135327292 | CMS |
| Medtronic, Inc. | $14.57 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119273206 | CMS |
| Nevro Corp. | $14.53 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130755153 | CMS |
| PFIZER INC. | $21.54 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131655986 | CMS |
| PFIZER INC. | $17.58 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132108731 | CMS |
| SCILEX PHARMACEUTICALS INC. | $19.91 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136233341 | CMS |
| SI-BONE, INC. | $22.23 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120067239 | CMS |
| Spinal Simplicity, LLC | $13.69 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144040911 | CMS |
| Spinal Simplicity, LLC | $17.64 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144040913 | CMS |
| SPR Therapeutics, Inc | $3.80 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951267 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.